A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02). This is an ASCO Meeting Abstract from ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
A randomized controlled trial in Knox County Schools found that early elementary students receiving tutoring aligned with their core reading curriculum made the equivalent of 1.3 additional months of ...
Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the initiation of a Phase 2b randomized, ...
PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...
In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results